​​​​​

IBD Center Conference

IBD Center Conference

April 22, 2017

Baylor Charles A. Sammons Cancer Center • Dallas, Texas

Objectives

Designed to provide updates on the pathogenesis of IBD, the changing national and global epidemiologic trends and the burden of these diseases on patients and health care systems. 

Upon completion of this activity, participants should be able to:
  • Identify the mechanisms of actions of immunosuppressants and biologics
  • Discuss the outcome data in surgical patients treated with these drugs
  • Discuss comparative effectiveness of various agents in preventing post-op recurrence
  • Demonstrate the benefits and limitations of therapeutic drug monitoring
  • Explain the effectiveness of diet in controlling IBD
  • Identify benefits and limitations of chromoendoscopy

Statement of Need

The two main Inflammatory Bowel Diseases (IBD), Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, progressive idiopathic inflammatory disorders of the gastrointestinal (GI) tract. CD can affect any part of the GI tract, whereas UC affects the colon only.

A study using data from 2003-2004 estimated that approximately 436,000 Americans have CD and 512,000 have UC 1. The prevalence of CD was estimated at 151 per 100,000, while UC prevalence was estimated 178 per 100,000 1. A subsequent study using 2009 data estimated that 1,171,000 Americans have IBD (565,000 CD and 593,000 UC) 2. The protracted nature of these diseases exerts a major toll on patients in terms of need for chronic medical therapies, hospitalizations, surgery, health-related quality of life, economic productivity and social functioning. CD is responsible for $3.48 billion in total costs in the United States 3

Management of IBD is a complex, multidisciplinary process, made all the more difficult by the clinical heterogeneity of IBD and the lack of comparative effectiveness studies. Numerous studies have demonstrated practice variation, for example in the use of anti-inflammatory therapies, vaccinations and surgery. A recent study found significant variation among seven major US referral centers in the treatment of CD with immunomodulators 4. The practice variation points to areas of potential improvement in the quality of IBD care.

References
  1. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1424-9.
  2. Kappelman MD, Moore KR, Allen JK, Cook SF. Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population. Dig Dis Sci. 2013; 58(2): 519–525.
  3. Ganz ML, Sugarman R, Wang R, Hansen BB, Håkan-Bloch J. The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey. Inflamm Bowel Dis. 2016 May;22(5):1032-41.
  4. Ananthakrishnan AN, Kwon J, Raffals L, Sands B, Stenson WF, McGovern D, Kwon JH, Rheaume RL, Sandler RS. Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States. Clin Gastroenterol Hepatol. 2015 Jun;13(6):1197-200.

Program Agenda

Presentation materials, when available, maybe downloaded in pdf format. The password will be emailed to participants prior to the activity.

Saturday, April 22, 2017

Accreditation and Credit Designation

Accreditation

The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Credit Designation

The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Location

Meeting

The conference is held at the Baylor Charles A. Sammons Cancer Center on the Baylor University Medical Center at Dallas campus.

The Baylor University Medical Center campus encompasses many hospital buildings, programs and office buildings. Avariety of parking options are available, including self-park, valet, covered parking and private lots.

Download campus map

Address
Baylor Charles A. Sammons Cancer Center
Tom Hunt Auditorium, 10th Floor
3410 Worth Street
Dallas, TX 75246

Registration

Physicians

$75

APPs

$75

Fellows

Free

Contact Us

Check out all of our upcoming learning opportunities